Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Current Assets (2016 - 2025)

Historic Current Assets for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to $2.3 million.

  • China Pharma Holdings' Current Assets fell 3769.88% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 3769.88%. This contributed to the annual value of $3.3 million for FY2024, which is 4546.56% down from last year.
  • According to the latest figures from Q3 2025, China Pharma Holdings' Current Assets is $2.3 million, which was down 3769.88% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, China Pharma Holdings' Current Assets registered a high of $9.1 million during Q4 2021, and its lowest value of $2.3 million during Q3 2025.
  • In the last 5 years, China Pharma Holdings' Current Assets had a median value of $5.3 million in 2021 and averaged $5.1 million.
  • Per our database at Business Quant, China Pharma Holdings' Current Assets skyrocketed by 7086.59% in 2021 and then plummeted by 4546.56% in 2024.
  • China Pharma Holdings' Current Assets (Quarter) stood at $9.1 million in 2021, then crashed by 34.41% to $6.0 million in 2022, then increased by 0.54% to $6.0 million in 2023, then tumbled by 45.47% to $3.3 million in 2024, then dropped by 28.77% to $2.3 million in 2025.
  • Its last three reported values are $2.3 million in Q3 2025, $2.7 million for Q2 2025, and $2.9 million during Q1 2025.